All News Ilsung Is Co., Ltd.

Equities

A003120

KR7003120003

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
19,050 ^KRW	+0.79%		-3.20%	-19.45%

05-14	Ilsung Is Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ilsung Is Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	11/08/23	CI
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	11/08/23	CI
Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback announced on February 13, 2023, has expired with 598,487 shares, representing 29.77% for KRW 14,994.85 million.	10/08/23	CI
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 13, 2023.	15/05/23	CI
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Ilsung Pharmaceuticals Co., Ltd. announces an Equity Buyback for KRW 15,000 million worth of its shares.	13/02/23	CI
Ilsung Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.	12/02/23	CI
Ilsung Pharmaceuticals Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Tranche Update on Ilsung Pharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on February 9, 2022.	10/05/22	CI
Ilsung Pharmaceuticals Co. Ltd.’s Equity Buyback announced on February 9, 2022, has expired with 50,935 shares, representing 3.32% for KRW 4,220.26 million.	08/05/22	CI
Ilsung Pharmaceuticals Co., Ltd. announces an Equity Buyback for 53,200 shares.	09/02/22	CI
Ilsung Pharmaceuticals Co., Ltd. authorizes a Buyback Plan.	08/02/22	CI
Cheil Industries Inc. completed the acquisition of Samsung C&T Corporation from a group of shareholders.	30/08/15	CI
Ilsung Seeks To Sell Stake In Samsung C&T	07/08/15	CI
Samsung C&T : Proxy advisor urges Samsung C&T holders to reject $8 billion merger	02/07/15	RE
Samsung C&T : Cheil, pitching $8 billion merger, pledges higher returns	30/06/15	RE
Ilsung Pharmaceuticals Co. Ltd.(KOSE:A003120) added to Russell Global Index	29/06/15	CI
Cheil Industries Inc. agreed to acquire Samsung C&T Corporation from a group of shareholders for KRW 8.4 trillion.	25/05/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Ilsung Is Co., Ltd.

Equities

A003120

KR7003120003

All News

Filters